Latest receivables for 9832.T: $55B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), 9832.T shows a receivables of $55B. That compares with $50B in the prior-year period — up 11.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 9832.T's receivables is now $55B (was $50B) — a 11.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Autobacs Seven , Ltd. is outperforming or lagging.
Tracking 9832.T's receivables over time shows whether Autobacs Seven , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $55B That compares with $50B in the prior-year period — up 11.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Autobacs Seven , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $55B) with ownership activity and broader fundamentals.